Combatting HIV using gene therapy
Researchers have created a nanomedicine loaded with siRNAs, which demonstrated a 73 percent reduction in HIV replication.
List view / Grid view
Researchers have created a nanomedicine loaded with siRNAs, which demonstrated a 73 percent reduction in HIV replication.
Researchers have discovered a new pathway which seems to be a significant contributor to the development of cardiovascular disease.
Researchers have gained a better understanding of the genes and biological processes that could influence POAG pathogenesis.
Researchers have found that using protein-like polymers to inhibit the Keap1/Nrf2 PPI is a powerful therapeutic strategy.
Researchers discover a mechanism that could be exploited for targeting other viruses that build capsids to hide from host defences.
Researchers have created a novel molecule, which has an improved ability to bind to bacterial ribosomes, with a completely synthetic system.
New immunotherapies may be developed for patients with HCC associated with steatotic liver disease, with TREM1 suggested as a target.
Single-cell RNA analysis provides an immunological explanation for the association between periodontitis and diabetes mellitus.
Researchers have discovered the role of two genes that protect mammalian germ cells, which could influence male fertility.
Using tumour organoids, researchers identified that overexpression of Engrailed-1 blocked genes associated with natural cell death.
For the first time, researchers reveal the involvement of OXT in object recognition memory through the supramammillary nucleus.
Researchers have created dual-targeted CARs, which performed better than single-targeted CARs in both in vivo and in vitro experiments.
Researchers have identified key differences between HSV-1 and HSV-2 and have developed monoclonal antibodies that could treat neonatal infections.
By studying the molecular cell states within transplanted paediatric hearts, researchers have unlocked new treatment strategies.
Low-dose positron emission mammography (PEM) has a high sensitivity for detecting cancer and reduces the likelihood of false positives.